Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1426.80
-11.95 (-0.83%) Cipla reports Profit after tax of Rs 3554.90 Mln, in the March 2023 quarter
Date: 26-07-2023
With no major difference for the quarter endedMarch 2023 , the total revenue stood at Rs. 38937.40 millions.The Company to register a -44.39% fall in the net profit for the quarter ended March 2023.The company reported a degrowth in operating Profit to 9194.90 millions from 9415.70 millions.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202303 | 202203 | % Var | 202303 | 202203 | % Var | 202303 | 202203 | % Var | |
| Sales | 38937.40 | 37345.90 | 4.26 | 157906.00 | 153808.20 | 2.66 | 157906.00 | 153808.20 | 2.66 |
| Other Income | 1197.10 | 3163.10 | -62.15 | 4567.90 | 6667.00 | -31.48 | 4567.90 | 6667.00 | -31.48 |
| PBIDT | 9194.90 | 9415.70 | -2.35 | 42493.70 | 43779.30 | -2.94 | 42493.70 | 43779.30 | -2.94 |
| Interest | 104.60 | 57.80 | 80.97 | 270.20 | 269.30 | 0.33 | 270.20 | 269.30 | 0.33 |
| PBDT | 7231.30 | 9357.90 | -22.73 | 40364.50 | 43510.00 | -7.23 | 40364.50 | 43510.00 | -7.23 |
| Depreciation | 1615.80 | 1367.20 | 18.18 | 5959.10 | 5466.20 | 9.02 | 5959.10 | 5466.20 | 9.02 |
| PBT | 5615.50 | 7990.70 | -29.72 | 34405.40 | 38043.80 | -9.56 | 34405.40 | 38043.80 | -9.56 |
| TAX | 2060.60 | 1598.60 | 28.90 | 9710.10 | 9218.00 | 5.34 | 9710.10 | 9218.00 | 5.34 |
| Deferred Tax | -385.80 | -0.50 | 77060.00 | -400.90 | -276.90 | 44.78 | -400.90 | -276.90 | 44.78 |
| PAT | 3554.90 | 6392.10 | -44.39 | 24695.30 | 28825.80 | -14.33 | 24695.30 | 28825.80 | -14.33 |
| Equity | 1614.30 | 1613.60 | 0.04 | 1614.30 | 1613.60 | 0.04 | 1614.30 | 1613.60 | 0.04 |
| PBIDTM(%) | 23.61 | 25.21 | -6.34 | 26.91 | 28.46 | -5.46 | 26.91 | 28.46 | -5.46 |